At BioRay, every patent is born from a health challenge we are determined to solve.

They are not meant to be locked in filing cabinets but to become real help in your life.

From an allergic child sleeping peacefully through the night to a senior regaining vitality in the morning, our innovation always serves life.

Our Promise: Creating Generation-Specific Health Solutions

We focus cutting-edge scientific research on what matters most in your daily life.

For the Sensitive Next Generation and You

[The Challenge We See]: Children scratching repeatedly from allergies, unable to sleep peacefully; you, on peritoneal dialysis, constantly worried about infection risks.

[Our Patented Solution]: We developed anti-allergy probiotic technology (BRAP-01) and pioneered preventive pharmaceutical compositions for peritonitis.

[The Meaning of This Promise]: A mother told us: "My child can finally sleep through the night without scratching his skin raw."
To date, our technology has helped over 200 kidney patients reduce infection risks.

[The Challenge We See]: Children scratching repeatedly from allergies, unable to sleep peacefully; you, on peritoneal dialysis, constantly worried about infection risks.

[Our Patented Solution]: We developed anti-allergy probiotic technology (BRAP-01) and pioneered preventive pharmaceutical compositions for peritonitis.

[The Meaning of This Promise]: A mother told us: "My child can finally sleep through the night without scratching his skin raw."
To date, our technology has helped over 200 kidney patients reduce infection risks.

Key Certifications

Immune Function Testing Laboratory Receives Taiwan FDA LDTS Recognition

The immune function testing laboratory has been officially listed as a Taiwan FDA Precision Medicine Molecular Testing Laboratory (Laboratory Developed Tests and Services, LDTS) (Certification No.: LDT0005), enabling clinical testing in compliance with hospital special management regulations.

Cell Culture Laboratory Passes Taiwan FDA GTP Inspection

BioRay Biotech Co., Ltd.'s immune cell laboratory cell preparation facility complies with Good Tissue Practice (GTP) standards. The application for cell preparation facility recognition has been approved by Taiwan FDA (Tainan Plant Recognition No.: TP110C026, Kaohsiung Plant Recognition No.: TP112C033).

Patented Technology Showcase

Micro-Pellet Formulation Patents (Colon-Targeted Release)
* Taiwan Patent: M356392 - Microsphere structure for colon-targeted release
* Taiwan Patent: M387067 - Formulation structure with carbon membrane layer
* China Patent: CN201315428Y - Microsphere for colon-targeted release
* China Patent: CN201840677U - Formulation structure with carbon membrane layer

Patented Micro-Pellet Formulation (Antrodia camphorata Micro-Pellets)

Antrodia camphorata micro-pellets effectively reduce damage to active ingredients from gastric acid. The coated membrane ensures targeted release and smooth delivery to the intestines, enabling stable and effective absorption by the human body.

* Taiwan Patent: M364520 - Immune-modulating formulation structure
* China Patent: CN201492710U - Immune-modulating formulation structure